The UCI insists Chris Froome's therapeutic use exemption for steroids did not break anti-doping rules.
A report in the French press suggested granting Froome permission to take penisolone, during this year's Tour de Romandie to treat a chill after Team Sky doctor Alan Farrell was given the go ahead by UCI medical director Mario Zorzoli, circumvented the strict regulations.
However, the governing body maintain "usual procedure" was followed in the way the Tour de France champion was dealt with.
In a statement, the UCI said: "Christopher Froome's TUE for oral use of glucocorticosteroids was granted on April 29 2014 based on duly documented medical history and in compliance with the applicable UCI regulations and the relevant WADA guidelines.
"The TUE was granted for a limited period, following the usual procedure.
"The process was fully transparent as it is UCI's policy to systematically record all TUEs on ADAMS.
"WADA was therefore informed throughout the process.
"The UCI wishes to emphasise that under the applicable rules - which are consistent with the WADA Code and the WADA TUE Standard and Guidelines - any rider with the same symptoms as Christopher Froome would have received a similar TUE."